Reaction

Haemorrhagic Erosive Gastritis reporting signals

Last recalculated 2026-09-14T18:28:35.993900+00:00 · 327 reports · 2 co-occurring drugs

As of the last recalculation, Haemorrhagic Erosive Gastritis appears in 327 FAERS reports alongside 2 co-occurring drug terms. The strongest observed disproportionality signal is RIVAROXABAN (PRR 53.0).

Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
DrugCo-reportsPRRROR
Rivaroxaban11453.053.0
Insulin Glulisine851.351.3

Related reactions

Data source: openFDA FAERS. See the OpenPV methodology and limitations.